The
challenges that exist in drug development from inception to FDA approval
are ever changing and well documented. Coupled with complex and unconnected
life sciences data, a lot of time is wasted exploring avenues that do not
result in an FDA-approved drug.
Please join
us for a webinar on November 6 as Dr. Gary Gustafson, experienced
medicinal chemist, shares his thoughts on the drug development journey,
demonstrating how solutions such as CAS SciFinder® and CAS BioFinder™
can be used to solve these common challenges.
Please
register even if you cannot attend the live session, a recording of the webinar
will be sent later. Feel free to forward this to anyone at your institution you
think may be interested.
|
Addressing
Challenges in Drug Development, from Idea to FDA Approval |
|
|
Wednesday,
November 6, 2024 |
|
|
8:00 AM ET
(US & Canada) |
12:00 PM ET
(US & Canada) |
|
|
|
Presenter
profile:
Dr. Gary
Gustafson, Ph.D.,
spent 25 years working as a medicinal chemist in the biotech industry,
developing therapeutics in several areas including CNS and oncology. Over the
course of his career, Gary has authored 45 scientific publications, including
28 patents, and is now a Senior Customer Success Specialist at CAS helping
scientific organizations and academic institutions adapt and overcome
challenges with drug discovery and development.
